Decrease of mitochondrial DNA content and energy metabolism in renal cell carcinoma

David Meierhofer1, Johannes A Mayr, Ulrike Foetschl

  • 1Department of Pediatrics, Paracelsus Private Medical University Salzburg, Muellner Hauptstr. 48, A-5020 Salzburg, Austria.

Carcinogenesis
|February 7, 2004
PubMed

Insights

Most renal carcinomas show reduced mitochondrial energy metabolism and mitochondrial DNA content early in formation. This down-regulation is consistent across different renal cancer types and does not change with disease progression.

Area of Science:

  • Oncology
  • Mitochondrial Biology
  • Biochemistry

Background:

  • Mitochondrial dysfunction is implicated in various cancers.
  • The role of mitochondrial energy metabolism in renal neoplasms requires further elucidation.

Purpose of the Study:

  • To investigate the relationship between tumor genesis and mitochondrial energy metabolism in renal carcinomas.
  • To assess specific enzyme activities of oxidative phosphorylation and the Krebs cycle, alongside mitochondrial DNA content.

Main Methods:

  • Analysis of three oxidative phosphorylation enzyme activities, two Krebs cycle components, and mitochondrial DNA content.
  • Comparison of 37 renal carcinoma tissues (conventional, papillary, sarcomatoid, collecting duct) with control kidney tissue.
  • Correlation analysis with tumor grade, metastasis, ploidy, and Ki-67 proliferative activity.

Main Results:

  • A significant reduction in all studied mitochondrial enzyme activities (including complex V) and mitochondrial DNA content was observed in 34 out of 37 renal carcinoma tissues.
  • No statistically significant differences in these parameters were found between conventional, papillary, and sarcomatoid renal carcinoma subtypes.
  • Mitochondrial alterations did not correlate with tumor grade, metastasis, ploidy, or proliferative activity.

Conclusions:

  • A coordinated down-regulation of mitochondrial energy metabolism components occurs early in the formation of most renal carcinomas.
  • This metabolic shift is a consistent feature across different renal carcinoma subtypes and remains stable throughout disease progression.

Related Concept Videos

Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...